Publications

Found 39 results
Author Title Type [ Year(Desc)]
Filters: First Letter Of Last Name is T  [Clear All Filters]
2015
Schwartz MP, Hou Z, Propson NE, Zhang J, Engstrom CJ, Costa VSantos, Jiang P, Nguyen BKim, Bolin JM, Daly W et al..  2015.  Human pluripotent stem cell-derived neural constructs for predicting neural toxicity.. Proc Natl Acad Sci U S A. 112(40):12516-21.
Zhao T, Zhang Z-ning, Westenskow PD, Todorova D, Hu Z, Lin T, Rong Z, Kim J, He J, Wang M et al..  2015.  Humanized Mice Reveal Differential Immunogenicity of Cells Derived from Autologous Induced Pluripotent Stem Cells.. Cell Stem Cell. 17(3):353-9.
McIntosh BE, Brown ME, Duffin BM, Maufort JP, Vereide DT, Slukvin II, Thomson JA.  2015.  Nonirradiated NOD,B6.SCID Il2rγ-/- Kit(W41/W41) (NBSGW) mice support multilineage engraftment of human hematopoietic cells.. Stem Cell Reports. 4(2):171-80.
Tomlinson BK, Thomson JA, Bomalaski JS, Diaz M, Akande T, Mahaffey N, Li T, Dutia MP, Kelly K, Gong I-Y et al..  2015.  Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors.. Clin Cancer Res. 21(11):2480-6.
Tomlinson BK, Thomson JA, Bomalaski JS, Diaz M, Akande T, Mahaffey N, Li T, Dutia MP, Kelly K, Gong I-Y et al..  2015.  Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors.. Clin Cancer Res. 21(11):2480-6.
Raval KK, Tao R, White BE, De Lange WJ, Koonce CH, Yu J, Kishnani PS, Thomson JA, Mosher DF, Ralphe JC et al..  2015.  Pompe disease results in a Golgi-based glycosylation deficit in human induced pluripotent stem cell-derived cardiomyocytes.. J Biol Chem. 290(5):3121-36.
Raval KK, Tao R, White BE, De Lange WJ, Koonce CH, Yu J, Kishnani PS, Thomson JA, Mosher DF, Ralphe JC et al..  2015.  Pompe disease results in a Golgi-based glycosylation deficit in human induced pluripotent stem cell-derived cardiomyocytes.. J Biol Chem. 290(5):3121-36.
Howden SE, Maufort JP, Duffin BM, Elefanty AG, Stanley EG, Thomson JA.  2015.  Simultaneous Reprogramming and Gene Correction of Patient Fibroblasts.. Stem Cell Reports. 5(6):1109-18.
2016
Chan SSun-Kin, Hagen HR, Swanson SA, Stewart R, Boll KA, Aho J, Thomson JA, Kyba M.  2016.  Development of Bipotent Cardiac/Skeletal Myogenic Progenitors from MESP1+ Mesoderm.. Stem Cell Reports. 6(1):26-34.
D'Souza SS, Maufort J, Kumar A, Zhang J, Smuga-Otto K, Thomson JA, Slukvin II.  2016.  GSK3β Inhibition Promotes Efficient Myeloid and Lymphoid Hematopoiesis from Non-human Primate-Induced Pluripotent Stem Cells.. Stem Cell Reports. 6(2):243-56.
Lalit PA, Salick MR, Nelson DO, Squirrell JM, Shafer CM, Patel NG, Saeed I, Schmuck EG, Markandeya YS, Wong R et al..  2016.  Lineage Reprogramming of Fibroblasts into Proliferative Induced Cardiac Progenitor Cells by Defined Factors.. Cell Stem Cell. 18(3):354-67.
Leng N, Choi J, Chu L-F, Thomson JA, Kendziorski C, Stewart R.  2016.  OEFinder: a user interface to identify and visualize ordering effects in single-cell RNA-seq data.. Bioinformatics.
Zanotelli MR, Ardalani H, Zhang J, Hou Z, Nguyen EH, Swanson S, Nguyen BKim, Bolin J, Elwell A, Bischel LL et al..  2016.  Stable engineered vascular networks from human induced pluripotent stem cell-derived endothelial cells cultured in synthetic hydrogels.. Acta Biomater. 35:32-41.
2017
Lin TC, Seiler MJ, Zhu D, Falabella P, Hinton DR, Clegg DO, Humayun MS, Thomas BB.  2017.  Assessment of Safety and Functional Efficacy of Stem Cell-Based Therapeutic Approaches Using Retinal Degenerative Animal Models. Stem Cells International. In Press

Pages